CSF2 and neoplasm: In subsequent clinical trials DC were differentiated in vitro from peripheral blood monocytes of patients using GM-CSF (granulocyte macrophage colony-stimulating factor) plus interleukin (IL)-4, pulsed with tumor lysate/proteins, matured, and reinfused [55].